Matak, I. (2020). Evidence for central antispastic effect of botulinum toxin type. British Journal of Pharmacology, 177. (1), 65-76. doi: 10.1111/bph.14846
Matak, Ivica. "Evidence for central antispastic effect of botulinum toxin type." British Journal of Pharmacology, vol. 177, br. 1, 2020, str. 65-76. https://doi.org/10.1111/bph.14846
Matak, Ivica. "Evidence for central antispastic effect of botulinum toxin type." British Journal of Pharmacology 177, br. 1 (2020): 65-76. https://doi.org/10.1111/bph.14846
Matak, I. (2020) 'Evidence for central antispastic effect of botulinum toxin type', British Journal of Pharmacology, 177(1), str. 65-76. doi: 10.1111/bph.14846
Matak I. Evidence for central antispastic effect of botulinum toxin type. British Journal of Pharmacology [Internet]. 01.2020. [pristupljeno 16.10.2024.];177(1):65-76. doi: 10.1111/bph.14846
I. Matak, "Evidence for central antispastic effect of botulinum toxin type", British Journal of Pharmacology, vol. 177, br. 1, str. 65-76, Siječanj 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:425846. [Citirano: 16.10.2024.]